George L. Sing
Chief Executive Officer, Stemnion, Inc. Managing Director, Lancet Capital
George L. Sing has been a Director of the Company since January 1988. Since 1998, he has been a Managing Director of Lancet Capital, a venture capital investment firm in the healthcare field. Since January 2004, Mr Sing has served as Chief Executive Officer of Stemnion, Inc., a bio-medical company in the regenerative medicine field.